Home Page         RUS ENG Home page Mail form Sitemap
 
       Articles
makita 9069ôàðìîöåôòèêà ëåêàðñòâàÑåãîäíÿ ñòðîèòåëüñòâî êîòòåäæåé Ïåòåðáóðã îò âåäóùèõ ïðîèçâîäèòåëåé.
2010/8/13
Clinical Trials in Russia. 2nd Quarter 2010
2010/5/17
Clinical Trials in Russia. 1st Quarter 2010
2010/2/24
Clinical Trials in Russia. Year 2009
2009/12/15
SynRG becomes the first Russian member of EF GCP
2009/11/28
GCP Training in Kazakhstan


 
 

Our core values are those of the Russian Troika: Speed, Cost, and Quality. Our success is driven by those factors crucial for each and every clinical trial. We break long-held stereotype that these three do not go together and you have to choose two of them – with us you do not!

Our goal is to shorten time to market for Sponsor’s drugs by providing the speedy patient recruitment and high data quality at reasonable costs using our strong Russian expertise, in-depth GCP knowledge and solid local presence. We achieve this goal by maintaining business relationships built on a thorough understanding of our clients’ needs and requirements, by creating true partnership with the clients, and by sharing strong commitment to excellence. Everyone at SynRG shares the same strong commitment to excellence.

Our mission is to improve people’s lives by helping our clients develop new safe and effective products to fight disease.

Maria Ilinskaya, CRA III
Maria Ilinskaya,
CRA III
  Synergy Research Group (SynRG™) is a leading Russian Contract Research Organization (CRO) since 2002.